According to some projections, Connecticut’s first full year of legalized weed sales may bring in between $300 million and $375 million. It’s possible… But the state of Connecticut is nowhere near ready for it. In fact, it isn’t ready for anything.
The administration had aimed for retail storefronts to open by the end of current year, that doesn’t look like it’s happening. That’ll start sometime next year now. They last claimed March, but who knows.
The following organizations are all set to go: Willow Brook Wellness in Meriden, Affinity in New Haven, Bluepoint Wellness in Branford, C3 Torrington (Still River Wellness), and Fine Fettle in Newington, Stamford, and Willimantic. However, they solely sell products for the medical patients currently. But they’re ready.
The four growers have to expand their operations to supply the recreational market while still servicing Connecticut’s medicinal cannabis patients. Which is around 50,000 patients and under state law are required to have a competent supply.
The needed actions were taken by only three of the four manufacturers, Advanced Grow Labs, Connecticut Pharmaceutical Solutions, and Curaleaf, to grow for the recreational market as well as medical patients. Plus all the new guys still have to come on-line.
What the hell? On July 1, 2021, it became lawful to consume cannabis on a recreational level. The state’s dispensaries, however, are only open to patients who need it for medical purposes and their caregivers until the recreational market opens.
If you liked this post, say thanks by sharing it